BioInvent and ThromboGenics Amending Long-Standing Monoclonal Antibody Development Agreement
Jul 10, 2017 05:31 am UTC| Business
PRESS RELEASE 10 July 2017 Lund, Sweden and Leuven, Belgium - 10 July 2017 - BioInvent International AB ("BioInvent") (OMXS: BINV) and ThromboGenics NV (Euronext Brussels: THR) today announce that...
ABcann and Cannabis Wheaton Announce Signing of Agreement for First Tranche $15 Million Investment
Jul 10, 2017 05:28 am UTC| Business
OTTAWA, July 10, 2017 -- Further to their joint news release dated May 29, 2017, ABcann Global Corporation (TSX.V:ABCN) (Frankfurt:23Q) (“ABcann”) and Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Cannabis Wheaton” or...
Plastic Surgery Specialty Organizations Band Together for Cleft and Craniofacial Awareness Month
Jul 10, 2017 05:12 am UTC| Business
Arlington Heights, IL, July 10, 2017 -- New statistics from the American Society of Plastic Surgeons (ASPS) reveal nearly 220,000 maxillofacial and craniofacial procedures were performed in the United States during...
Norsk Hydro: Hydro acquires Sapa to create a global aluminium champion
Jul 10, 2017 05:06 am UTC| Business
Norsk Hydro has agreed with Orkla to acquire its 50 percent interest in Sapa for a total enterprise value of NOK 27 billion, giving full ownership in the global leader in extruded aluminium solutions and making Hydro a...
Norsk Hydro: Hydro acquires Sapa to create a global aluminium champion
Jul 10, 2017 05:02 am UTC| Business
Norsk Hydro has agreed with Orkla to acquire its 50 percent interest in Sapa for a total enterprise value of NOK 27 billion, giving full ownership in the global leader in extruded aluminium solutions and making Hydro a...
SelectMDx to be Distributed Across Middle East by IPS Genomix
Jul 10, 2017 05:01 am UTC| Business
MDxHealth establishes commercial agreement with regional experts NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION HERSTAL, BELGIUM - July 10, 2017 - MDxHealth SA (Euronext: MDXH.BR) today announced...
Guerbet Announces Plans to Streamline Its Contrast Media Portfolio
Jul 10, 2017 05:01 am UTC| Business
Villepinte (France), July 10, 2017 (7:00 AM CET) - Guerbet (FR0000032526 GBT), the global specialist in contrast products and solutions for medical imaging, announced today that it will phase out sales...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects